Natixis Lowers Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Natixis lessened its position in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 83.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,824 shares of the company's stock after selling 9,319 shares during the period. Natixis' holdings in Revvity were worth $204,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Norinchukin Bank The lifted its holdings in Revvity by 7.8% during the fourth quarter. Norinchukin Bank The now owns 5,448 shares of the company's stock valued at $608,000 after purchasing an additional 396 shares during the last quarter. Ossiam lifted its stake in shares of Revvity by 5.2% during the 4th quarter. Ossiam now owns 7,395 shares of the company's stock valued at $825,000 after buying an additional 363 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S grew its stake in Revvity by 89.9% in the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 4,016 shares of the company's stock valued at $448,000 after buying an additional 1,901 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Revvity by 5.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,295,760 shares of the company's stock valued at $144,621,000 after purchasing an additional 70,867 shares during the period. Finally, Forum Financial Management LP grew its holdings in Revvity by 51.9% during the 4th quarter. Forum Financial Management LP now owns 3,545 shares of the company's stock valued at $396,000 after buying an additional 1,211 shares in the last quarter. Institutional investors own 86.65% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Raymond James restated an "outperform" rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Barclays lowered their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Wells Fargo & Company cut their target price on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Sanford C. Bernstein downgraded Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target on the stock. in a research report on Friday, January 10th. Finally, KeyCorp upped their price objective on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Revvity presently has an average rating of "Moderate Buy" and an average price target of $130.50.

Revvity Trading Up 0.8 %

NYSE:RVTY traded up $0.71 during mid-day trading on Monday, reaching $95.00. 2,062,733 shares of the company's stock traded hands, compared to its average volume of 918,756. Revvity, Inc. has a 12-month low of $88.53 and a 12-month high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The company has a 50 day moving average price of $104.87 and a 200-day moving average price of $112.98. The firm has a market capitalization of $11.41 billion, a price-to-earnings ratio of 42.99, a PEG ratio of 3.82 and a beta of 1.07.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The firm's revenue for the quarter was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.98 earnings per share. On average, sell-side analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is 12.67%.

Insider Activity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares in the company, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.68% of the company's stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.